chr14-56633141-GTATC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_017799.4(TMEM260):c.1698_1701del(p.Tyr567ThrfsTer27) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. S565S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
TMEM260
NM_017799.4 frameshift
NM_017799.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.19
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 14-56633141-GTATC-G is Pathogenic according to our data. Variant chr14-56633141-GTATC-G is described in ClinVar as [Pathogenic]. Clinvar id is 426076.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr14-56633141-GTATC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM260 | NM_017799.4 | c.1698_1701del | p.Tyr567ThrfsTer27 | frameshift_variant | 13/16 | ENST00000261556.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM260 | ENST00000261556.11 | c.1698_1701del | p.Tyr567ThrfsTer27 | frameshift_variant | 13/16 | 2 | NM_017799.4 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Structural heart defects and renal anomalies syndrome Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | Sep 08, 2021 | Truncating mutations of TMEM260 with autosomal recessive inheritance have been reported in multiple families and are associated with exhibited complex congenital heart defects, including atrial and ventricular septal defects (ASDs and VSDs). Tyr567Thrfs*27 was published in a case (Ta-Shma et al 2017) and two further cases (Pagnamenta et al (in press)). Functional studies (Ta-Shma et al 2017) showed reduced levels of only the long isoform, suggesting that the mutation induces nonsense-mediated decay. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 08, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at